If FGFR2+ CAFs are originated from BM, before arriving in tumor beds, they or their precursors should be mobilized in BM and thereafter introduced into peripheral circulation in response to ESCC stimuli. The gene discussed is FGFR2; the disease is esophageal squamous cell carcinoma.